Novo Nordisk Investor Presentation - First Nine Months of 2016

Investor presentation First nine months of 2016 Slide 54 Increasing global GLP-1 volume growth across all regions 60% 50% 40% 30% 20% 10% Regional GLP-1 volume growth USA Pacific - Europe Int. Operations World - 0% Aug 2013 Regional GLP-1 volume market split Region China 100% 80% 60% 23.6% 40% 20% 0% Aug 2016 Aug 2013 Note: Data is sensitive to changes in IMS data collection and reporting methodology Source: IMS Monthly MAT August, 2016 volume figures changing diabetes USA Int. Operations Europe Pacific Region China 1% 5% 10% Note: Data is sensitive to changes in IMS data collection and reporting methodology Source: IMS Monthly MAT August, 2016 volume figures 40% 44% Aug 2016 novo nordisk

View entire presentation